Effect of a Nurse-Navigated Game-Based Program on Transition Readiness and Psychosocial Outcomes in Adolescents With Osteosarcoma: A Cluster-Nonrandomized Controlled Study.

PsychooncologySep 1, 2026
Clinical ResearchOncology (Medical)PediatricsOpen access

Jun Ma, Xia Zhang, Jing Li et al.

✦ AI-curated · Sources linked

In 30 seconds

This cluster-nonrandomized controlled study evaluated the impact of a nurse-navigated game-based intervention (N2-GBI) on transition readiness in 59 adolescents with osteosarcoma. The intervention group demonstrated significant improvements in transition readiness at both immediate post-intervention (β = 8.83, p < 0.001) and 12-week follow-up (β = 7.97, p = 0.001), alongside reduced cancer worry and increased patient activation.

Key findings

  • The N2-GBI group showed significant improvement in transition readiness at T1 (β = 8.83, p < 0.001).
  • At T2, the N2-GBI group maintained significant improvement in transition readiness (β = 7.97, p = 0.001).
  • Cancer worry was significantly reduced in the N2-GBI group (p = 0.009).
  • Patient activation increased significantly in the N2-GBI group (p = 0.001).

Why it matters

Improving transition readiness and psychosocial outcomes in adolescents with osteosarcoma is crucial for their development and long-term health. Effective interventions can enhance their ability to manage health as they transition to adulthood.

Source

PubMed · PMID 42684068Free full text on PubMed Central

Published in Psychooncology. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.